Dupuytren's Contracture

Clinical Comprehensive Guide: Dupuytren’s Contracture (Palmar Fibromatosis)

1. Comprehensive Introduction & Overview

Dupuytren’s Contracture, clinically referred to as palmar fibromatosis, is a fibroproliferative disorder of the palmar fascia characterized by the progressive shortening, thickening, and fibrosis of the fascia. This anatomical transformation leads to fixed flexion deformities of the digits, most commonly affecting the fourth (ring) and fifth (little) fingers.

First described extensively by Baron Guillaume Dupuytren in 1831, the condition represents a benign but functionally debilitating transformation of the palmar aponeurosis. While historically associated with Northern European descent (often termed "Viking Disease"), it is a global clinical entity. It is not merely a "tightening" of the skin; it is a complex molecular and cellular dysregulation of myofibroblasts.

The clinical trajectory is typically slow, beginning with palmar nodules and progressing over months or years into rigid cords that tether the digits toward the palm, ultimately compromising grip, hygiene, and fine motor dexterity.

2. Technical Specifications and Pathophysiology

The Cellular Mechanism

The pathophysiology of Dupuytren’s is defined by the transformation of fibroblasts into myofibroblasts. Under normal conditions, palmar fascia is composed of Type I collagen. In Dupuytren’s, there is a pathological shift toward Type III collagen and an unregulated proliferation of myofibroblasts, which express alpha-smooth muscle actin (α-SMA).

The process occurs in three distinct phases:
1. Proliferative Phase: Intense myofibroblast activity; high cellularity; formation of the initial nodule.
2. Involutional Phase: Myofibroblasts align along the lines of tension; collagen deposition increases.
3. Residual Phase: High density of hypocellular collagen; formation of the mature, thick "cord" that creates the contracture.

Anatomical Mapping

The contracture occurs within the longitudinal fibers of the palmar aponeurosis. Key anatomical structures affected include:
* Pre-tendinous cords: Extension of the palmar fascia into the digit.
* Spiral cords: A pathological structure formed by the connection of the pre-tendinous cord, the spiral band, the lateral digital sheet, and Grayson’s ligament. This specific cord is notorious for displacing the neurovascular bundle toward the midline, increasing the risk of iatrogenic injury during surgical intervention.

3. Clinical Staging and Grading

To standardize treatment, clinicians utilize the Tubiana Classification System, which measures the total passive extension deficit (the sum of the flexion contractures of the MCP and PIP joints).

Tubiana Stages

• Stage 0: No lesion.
• Stage N: Nodule or pit only, no contracture.
• Stage I: Total contracture 0°–45°.
• Stage II: Total contracture 45°–90°.
• Stage III: Total contracture 90°–135°.
• Stage IV: Total contracture >135°.

4. Clinical Indications & Standard Presentation

Presentation

Patients typically present in the 5th or 6th decade of life. The earliest sign is a painless, firm nodule in the palm, often near the distal palmar crease. Over time, the skin becomes "puckered" or "dimpled" due to the attachment of the fascia to the dermis. As the cord matures, the patient notices an inability to lay the hand flat on a tabletop, known as the Tabletop Test.

Key Diagnostic Indicators

1. Physical Inspection: Palpation of cords and nodules.
2. Tabletop Test: A positive result is the inability to place the palm flat on a surface.
3. Neurovascular Assessment: Always assess sensation (digital nerves) prior to any procedural intervention.
4. Hueston’s Tabletop Test: A functional benchmark for surgical referral.

Differential Diagnosis

It is critical to distinguish Dupuytren’s from other hand pathologies:
* Trigger Finger (Stenosing Tenosynovitis): Involves the tendon sheath, not the fascia; characterized by "locking" rather than fixed flexion.
* Camptodactyly: Congenital flexion deformity of the PIP joint.
* Scar Contracture: Post-traumatic or post-burn scarring.
* Epithelioid Sarcoma: Rare, but must be considered if the nodule grows rapidly or is painful.

5. Risks, Side Effects, and Contraindications

Surgical Risks (Fasciectomy)

• Neurovascular Injury: The primary concern; digital nerves are frequently displaced by spiral cords.
• Hematoma: The most common postoperative complication.
• Flare Reaction: Complex Regional Pain Syndrome (CRPS) or excessive postoperative edema.
• Recurrence: High risk of recurrence within the same digit or development of disease in other digits.

Non-Surgical Risks (Collagenase/Needle Aponeurotomy)

• Tendon Rupture: Rare but severe.
• Skin Lacerations: Common with needle aponeurotomy.
• Incomplete Correction: Higher rate of residual contracture compared to open fasciectomy.

6. Long-Term Prognosis

Dupuytren’s is a lifelong condition. Treatment is aimed at restoring function, not curing the underlying genetic predisposition.
* The "Diathesis" Factor: Patients with a strong family history, bilateral involvement, ectopic deposits (Ledderhose disease in feet, Peyronie’s disease in the penis), and early onset are at high risk for aggressive recurrence.
* Functional Outcomes: Most patients achieve significant improvement in hand function following intervention. However, long-term maintenance often requires a multidisciplinary approach involving hand therapy, splinting, and ongoing monitoring.

7. Massive FAQ Section

1. Is Dupuytren’s Contracture painful?

Usually, it is painless. If a patient experiences significant pain, it may suggest a rapidly growing nodule or an alternative diagnosis like an inflammatory process.

2. Can physical therapy cure Dupuytren’s?

No. Physical therapy cannot reverse the collagen deposition of the cords. However, therapy is essential post-surgery to manage scar tissue and regain range of motion.

3. What is the "Viking Disease" connection?

The condition is highly prevalent in populations of Northern European descent, leading to the colloquial term "Viking Disease," though it is now understood to be present globally.

4. When is surgery recommended?

Surgery is typically indicated when the contracture prevents the patient from placing their hand flat on a table (positive Tabletop Test) or when the contracture begins to interfere with activities of daily living (ADLs).

5. Does the condition affect both hands?

Yes, it is often bilateral, though one hand is frequently more advanced than the other.

6. What is the difference between an open fasciectomy and a needle aponeurotomy?

An open fasciectomy involves surgical excision of the diseased tissue, while a needle aponeurotomy is a minimally invasive technique that uses a needle to "break" the cord under local anesthesia.

7. What is Ledderhose disease?

Ledderhose disease is plantar fibromatosis, which is the equivalent of Dupuytren’s occurring in the soles of the feet. A subset of Dupuytren’s patients also develops this.

8. Is there a genetic component?

Yes. There is a strong autosomal dominant inheritance pattern with variable penetrance. It is highly linked to family history.

9. What lifestyle factors exacerbate the condition?

While not definitively caused by manual labor, repetitive trauma or vibration may contribute to the progression of the disease in genetically susceptible individuals.

10. Can it come back after surgery?

Yes. Recurrence is common, especially in patients with "Dupuytren’s Diathesis" (early onset, family history, and ectopic disease).

8. Clinical Management Summary Table

Disclaimer: This guide is for educational purposes for clinical professionals and medical students. It does not replace the judgment of a board-certified orthopedic or plastic surgeon. Always consult clinical guidelines and patient-specific history before recommending a treatment path.